Elf Brand Accused of Cloning ELFBAR's Design

MarketBusiness by Leona Zhu; Ashe Wong
May.12.2023
Elf Brand Accused of Cloning ELFBAR's Design
ELFBAR alleges design infringement by VPR's ELF brand in the US.

Accusations of Design Imitation

On May 11th, inside sources informed 2FIRSTS that at the CHAMPS e-cigarette exhibition in the United States, the ELF brand under American e-cigarette company VPR, launched a new product named "ELFBAR". This new product shares not only its name with the "ELFBAR" brand under Shenzhen iMiracle, but its exterior design is also strikingly similar.

 

Notable Differences Between the Products

After comparing images provided by these sources, 2FIRSTS found a few subtle differences between the two products:

  • Different logos: ELFBAR has a "petal and bubble" pattern; ELF has a "jester hat sketch" pattern (see picture 1 below).
  • Different model markings: ELFBAR's is "BC"; ELF's is "BP" (see picture 2 below).
  • Additionally, ELF's packaging is marked with the word "ORIGINAL" (see picture 1 and 2 below).

 

Elf Brand Accused of Cloning ELFBAR's Design
Picture 1: Logo difference | Anonymous insider

 

Elf Brand Accused of Cloning ELFBAR's Design
Picture 2: Product difference | Anonymous insider

 

Prior Lawsuits and Trademark Issues

As previously reported by 2FIRSTS, in February this year, VPR filed a lawsuit against the parent company of "ELFBAR" for allegedly infringing on its "ELF" e-cigarette trademark. Subsequently, a judge ordered Shenzhen Wei Bo Li and iMiracle (Hong Kong) to cease "ELFBAR" marketing activities in the US. Based on the trial outcome, Shenzhen Wei Bo Li and iMiracle (Hong Kong) temporarily stopped using the "ELFBAR" trademark in the US, switching to "EB DESIGN" for US sales, while continuing to appeal the trademark case.

 

Countersuit by Shenzhen Wei Bo Li and iMiracle

In early May, LAW360 reported that Shenzhen Wei Bo Li and iMiracle (Hong Kong) filed a countersuit against American e-cigarette company VPR for preparing to launch a disposable e-cigarette product that "blatantly imitates" ELFBAR.

 

VPR's Defense

VPR argued that "ELF" is its registered trademark, which had no connection with the e-cigarette industry before its registration. Shenzhen Wei Bo Li and iMiracle (Hong Kong) changing it to "ELFBAR" does not make it a proprietary term, as "bar" is a common term for a specific shape of e-cigarette, and thus consumers would still consider ELFBAR a part of the ELF brand.

 

iMiracle's Response

In response to this, 2FIRSTS contacted iMiracle for updates on the case. iMiracle stated that they are seeking an injunction from the US court to prevent VPR from infringing on their products. Regarding VPR's actions at the CHAMPS exhibition, iMiracle said that they are already aware of the incident and are considering further legal action.

 


Thumbnail source: Anonymous

 

 

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai